Elan offers Tysabri dividend after Royalty approach
DUBLIN (Reuters) - Irish drugmaker Elan said it will give shareholders 20 percent of the royalty rights for multiple sclerosis drug Tysabri in a bid t...
Source: http://health.yahoo.net/news/s/nm/elan-offers-tysabri-dividend-after-royalty-approach
No comments:
Post a Comment